Review: taking Metoprolol tartrate and Furosemide together


Summary

Drug interactions are reported among people who take Metoprolol tartrate and Furosemide together. This review analyzes the effectiveness and drug interactions between Metoprolol tartrate and Furosemide. It is created by eHealthMe based on reports of 20,821 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Metoprolol Tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 46,720 users)

Furosemide

Furosemide has active ingredients of furosemide. It is often used in high blood pressure. (latest outcomes from Furosemide 121,371 users)

On Sep, 20, 2016

20,821 people who take Metoprolol Tartrate, Furosemide are studied.


Number of reports submitted per year:

Metoprolol tartrate and Furosemide drug interactions.

Drug effectiveness over time:

Metoprolol Tartrate:
  • < 1 month: 20.0% - (2 of 10 people)
  • 1 - 6 months: 40.0% - (8 of 20 people)
  • 6 - 12 months: 27.0% - (3 of 11 people)
  • 1 - 2 years: 17.0% - (5 of 29 people)
  • 2 - 5 years: 29.0% - (9 of 31 people)
  • 5 - 10 years: 76.0% - (19 of 25 people)
  • 10+ years: 71.0% - (10 of 14 people)
  • not specified: 0.0% - (0 of 1 people)
Furosemide:
  • < 1 month: 18.0% - (2 of 11 people)
  • 1 - 6 months: 13.0% - (4 of 29 people)
  • 6 - 12 months: 25.0% - (5 of 20 people)
  • 1 - 2 years: 43.0% - (7 of 16 people)
  • 2 - 5 years: 35.0% - (14 of 39 people)
  • 5 - 10 years: 47.0% - (9 of 19 people)
  • 10+ years: 75.0% - (6 of 8 people)
  • not specified: 75.0% - (3 of 4 people)

Drug effectiveness by gender:

Metoprolol Tartrate:
  • female: 40.0% - (32 of 79 people)
  • male: 38.0% - (24 of 62 people)
Furosemide:
  • female: 32.0% - (26 of 79 people)
  • male: 35.0% - (24 of 67 people)

Drug effectiveness by age:

Metoprolol Tartrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 33.0% - (2 of 6 people)
  • 40-49: 54.0% - (6 of 11 people)
  • 50-59: 51.0% - (15 of 29 people)
  • 60+: 35.0% - (33 of 94 people)
Furosemide:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 1 people)
  • 30-39: 60.0% - (3 of 5 people)
  • 40-49: 36.0% - (4 of 11 people)
  • 50-59: 26.0% - (8 of 30 people)
  • 60+: 35.0% - (35 of 99 people)

Most common drug interactions over time *:

< 1 month:
  • renal failure
  • pain
  • anxiety
  • injury
  • fear
  • dehydration
  • pneumonia
  • anaemia
  • emotional distress
  • multi-organ failure
1 - 6 months:
  • dyspnoea
  • anaemia
  • renal failure
  • cardiac failure congestive
  • hypertension
  • myocardial infarction
  • cerebrovascular accident
  • chest pain
  • coronary artery disease
  • oedema peripheral
6 - 12 months:
  • pneumonia
  • skin ulcer
  • anaemia
  • gastrointestinal haemorrhage
  • impaired healing
  • hypotension
  • death
  • hives
  • insomnia
  • lobar pneumonia
1 - 2 years:
  • renal impairment
  • cardiac failure
  • dehydration
  • nervousness
  • cerebrovascular accident
  • malaise
  • renal failure acute
  • angina pectoris
  • cardiac failure congestive
  • lightheadedness - fainting
2 - 5 years:
  • gastrointestinal haemorrhage
  • myocardial infarction
  • anaemia
  • rectal haemorrhage
  • oedema peripheral
  • insomnia
  • pneumonia
  • renal failure acute
  • cardiac failure
  • fatigue
5 - 10 years:
  • gastrointestinal haemorrhage
  • intussusception
  • confusion
  • haemorrhagic anaemia
  • rectal haemorrhage
  • renal failure
  • anaemia
  • cerebrovascular accident
  • fall
  • renal failure acute
10+ years:
  • gastrointestinal haemorrhage
  • anaemia
  • renal failure acute
  • anxiety
  • bradycardia
  • fatigue
  • pain
  • renal failure
  • cerebrovascular accident
  • confusion
not specified:
  • dyspnoea
  • cardiac failure congestive
  • pain
  • fatigue
  • myocardial infarction
  • nausea
  • asthenia
  • anxiety
  • anaemia
  • oedema peripheral

Most common drug interactions by gender *:

female:
  • dyspnoea
  • cardiac failure congestive
  • pain
  • nausea
  • fatigue
  • anaemia
  • anxiety
  • asthenia
  • fall
  • oedema peripheral
male:
  • cardiac failure congestive
  • dyspnoea
  • pain
  • renal failure
  • anxiety
  • myocardial infarction
  • pneumonia
  • fatigue
  • asthenia
  • injury

Most common drug interactions by age *:

0-1:
  • blood creatinine increased
  • cardiac hypertrophy
  • drug ineffective
  • hypertrichosis
  • proteinuria
  • activated partial thromboplastin time prolonged
  • agitation
  • apnoea
  • blood fibrinogen decreased
  • blood urea increased
2-9:
  • accidental exposure
  • cardiac arrest
  • respiratory arrest
  • abasia
  • arthralgia
  • bursitis
  • femur fracture
  • hypothyroidism
  • overdose
  • pain in extremity
10-19:
  • completed suicide
  • posterior reversible encephalopathy syndrome
  • vomiting
  • blood pressure increased
  • death
  • headache
  • hypotension
  • nausea
  • pyrexia
  • visual impairment
20-29:
  • pain
  • anxiety
  • nausea
  • dyspnoea
  • emotional distress
  • renal failure
  • injury
  • urinary tract infection
  • cardiac failure congestive
  • vomiting
30-39:
  • dyspnoea
  • pain
  • oedema peripheral
  • anxiety
  • cardiac failure congestive
  • hypotension
  • myocardial infarction
  • pain in extremity
  • fatigue
  • dizziness
40-49:
  • pain
  • cardiac failure congestive
  • anxiety
  • nausea
  • renal failure
  • myocardial infarction
  • vomiting
  • dyspnoea
  • injury
  • emotional distress
50-59:
  • cardiac failure congestive
  • pain
  • dyspnoea
  • anxiety
  • myocardial infarction
  • fatigue
  • nausea
  • oedema peripheral
  • renal failure
  • anaemia
60+:
  • dyspnoea
  • cardiac failure congestive
  • pain
  • atrial fibrillation
  • fatigue
  • anaemia
  • asthenia
  • nausea
  • myocardial infarction
  • pneumonia

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Metoprolol tartrate and Furosemide?

Can you answer these questions?

More questions for: Metoprolol tartrate, Furosemide

You may be interested in these reviews

More reviews for: Metoprolol tartrate, Furosemide

On eHealthMe, Metoprolol tartrate (metoprolol tartrate) is often used to treat high blood pressure. Furosemide (furosemide) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.